Key result
Acute hepatitis E infection preceded Guillain-Barré syndrome in a European patient, with antiganglioside GM2 antibodies suggesting molecular mimicry as the underlying mechanism.
Case Report (n=1)
This case report suggests that molecular mimicry involving ganglioside GM2 may play a role in the pathogenesis of Guillain-Barré syndrome triggered by acute hepatitis E.
Answers are grounded in this paper and cite their sources.
Raises awareness for hepatitis E testing in Guillain-Barré syndrome; hypothesis-generating for molecular mimicry and requires larger studies.
Guillain-Barré syndrome (GBS) is often triggered by a preceding bacterial or viral infection. Occasionally, it has been observed in association with acute hepatitis A, B and C, and three cases have been previously described in India in which GBS was associated with acute hepatitis E. A molecular mimicry mechanism is supposed to be involved in the pathogenesis of GBS triggered by infectious agents, although the nature of the shared epitopes has not been characterized in most instances, including that in the case of hepatotropic viruses. We report a case of GBS following acute hepatitis E in a European individual. The presence of antiganglioside GM2 antibodies in this patient suggested molecular mimicry involving ganglioside GM2 in the pathogenesis of GBS associated with hepatitis E.
No takes yet. Share an insight, caveat, or question.
Loly et al. (2009) conducted a case report in Guillain-Barré syndrome following acute hepatitis E (n=1). Acute hepatitis E infection was evaluated on Development of Guillain-Barré syndrome and presence of antiganglioside GM2 antibodies. Acute hepatitis E infection preceded Guillain-Barré syndrome in a European patient, with antiganglioside GM2 antibodies suggesting molecular mimicry as the underlying mechanism.
Synapse has enriched 10 related papers. Consider them for comparative context: